CRPC w/ Bone Metastases - Results from #40

Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis. September 11, 2020

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center. September 10, 2020

Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases. September 9, 2020

Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents. September 8, 2020

Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials. September 7, 2020

Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases. September 4, 2020

Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI. August 31, 2020

Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy. August 27, 2020

Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases. August 26, 2020

Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study. August 25, 2020

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. August 20, 2020

Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application. August 19, 2020

Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer. August 18, 2020

Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence? August 17, 2020

Efficient Bone Metastasis Diagnosis in Bone Scintigraphy Using a Fast Convolutional Neural Network Architecture. August 10, 2020

Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223. August 6, 2020

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases. August 5, 2020

Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases. July 21, 2020

Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study. July 20, 2020

Bone, a Secondary Growth Site of Breast and Prostate Carcinomas: Role of Osteocytes. July 14, 2020

Page 3 of 13